INTERCEPT PHARMACEUTICALS, INC. 4/A SEC Filings

Filed On	Filing
23 Aug 2019	Form 4/A: Akkaraju Srinivas, Director Bought 37,604 shares ($2.48M) · Bought 29,000 shares ($1.95M) · Bought 1,180 shares ($75.9K)

Comments